I agree that this site is using cookies. You can find further informations here.
X
Killestein, Joep
368  results:
Search for persons X
?
1

Outcome Reporting Bias in Clinical Trials Researching Disea..:

Lemmens, Cynthia M.C. ; van Amerongen, Suzan ; Strijbis, Eva M..
Neurology.  102 (2024)  6 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
2

ENSEMBLE PLUS: final results of shorter ocrelizumab infusio..:

Hartung, Hans-Peter ; Berger, Thomas ; Bermel, Robert A....
Journal of Neurology.  271 (2024)  7 - p. 4348-4360 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Suppressed IgG4 class switching in dupilumab‐ and TNF inhib..:

Valk, Anika M. ; Keijser, Jim B. D. ; van Dam, Koos P. J....
Allergy.  79 (2024)  7 - p. 1952-1961 , 2024
Link: https://doi.org/10.1111/..
 
?
4

Information from ecological momentary assessments lead to o..:

de Jong, Daan J ; Strijbis, Eva M ; Killestein, Joep
Multiple Sclerosis Journal.  , 2024
Link: https://doi.org/10.1177/..
 
?
5

Practical clinical predictions: development and validation ..:

Fuchs, Tom A. ; Zivadinov, Robert ; Pryshchepova, Tetyana...
Multiple Sclerosis and Related Disorders.  , 2024
Link: https://doi.org/10.1016/..
 
?
6

Exploring the effects of extended interval dosing of natali..:

Toorop, Alyssa A ; Noteboom, Samantha ; Steenwijk, Martijn D...
Multiple Sclerosis Journal.  30 (2024)  2 - p. 266-271 , 2024
Link: https://doi.org/10.1177/..
 
?
7

Surrogate endpoints for progressive multifocal leukoencepha..:

Killestein, Joep ; Wattjes, Mike P
The Lancet Neurology.  23 (2024)  5 - p. 455-456 , 2024
Link: https://doi.org/10.1016/..
 
?
8

T cell activation markers CD38 and HLA-DR indicative of non..:

Verstegen, Niels J M ; Hagen, Ruth R ; Kreher, Christine...
Journal of Neurology, Neurosurgery & Psychiatry.  , 2024
Link: https://doi.org/10.1136/..
 
?
9

Résultats de l'étude d'extension NOVA évaluant la préférenc..:

Wiendl, Heinz ; Foley, John ; Defer, Gilles...
Revue Neurologique.  180 (2024)  - p. S145 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Clinical and humoral response after SARS-CoV-2 breakthrough..:

Stalman, Eileen W. ; Wieske, Luuk ; Keijser, Jim B.D....
Journal of Allergy and Clinical Immunology.  , 2024
Link: https://doi.org/10.1016/..
 
?
11

Successful epilepsy surgery in two cases with multiple scle..:

van Klink, Nicole ; Tousseyn, Simon ; Schijns, Olaf...
Epileptic Disorders.  25 (2023)  6 - p. 890-894 , 2023
Link: https://doi.org/10.1002/..
 
?
12

Longitudinal increase of humoral responses after four SARS-..:

van Kempen, Zoé LE ; van Dam, Koos PJ ; Keijser, Jim BD...
Multiple Sclerosis Journal.  30 (2023)  3 - p. 443-447 , 2023
Link: https://doi.org/10.1177/..
 
?
13

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P. J. ; Volkers, Adriaan G. ; Wieske, Luuk...
BMC Infectious Diseases.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
14

Cognitive performance in multiple sclerosis: what is the ro..:

Huiskamp, Marijn ; Yaqub, Maqsood ; van Lingen, Marike R...
Brain Communications.  5 (2023)  3 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
15

Exploratory clinical efficacy and patient-reported outcomes..:

Ryerson, Lana Zhovtis ; Foley, John F ; Defer, Gilles...
Multiple Sclerosis and Related Disorders.  72 (2023)  - p. 104561 , 2023
Link: https://doi.org/10.1016/..
 
1-15